Global Hemato Oncology Testing Market Size, Share, and COVID-19 Impact Analysis, By Product (Assay Kits & Reagents, and Services), By Cancer Type (Leukemia, Lymphoma, and Multiple Myeloma), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Immunohistochemistry (IHC), & Others), By End User (Hospitals, Academic & Research Institutes, & Others), By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2022 - 2032.

Industry: Healthcare
RELEASE DATE Jun 2024
REPORT ID SI2489
PAGES 249
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Product
      2. Market Attractiveness Analysis, By Cancer Type
      3. Market Attractiveness Analysis, By Technology
      4. Market Attractiveness Analysis, By End User
      5. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. increased availability of sophisticated molecular methods for hemato oncology diagnosis
    3. Restraints
      1.  Unfavorable reimbursement scenario
    4. Opportunities
      1.  Emerging markets
    5. Challenges
      1. Intellectual property rights protection issues
  6. Global Hemato Oncology Testing Market Analysis and Projection, By Product
    1. Segment Overview
    2. Assay Kits & Reagents
    3. Services
  7. Global Hemato Oncology Testing Market Analysis and Projection, By Cancer Type
    1. Segment Overview
    2. Leukemia
    3. Lymphoma
    4. Multiple Myeloma
  8. Global Hemato Oncology Testing Market Analysis and Projection, By Technology
    1. Segment Overview
    2. Polymerase Chain Reaction (PCR)
    3. Next-Generation Sequencing (NGS)
    4. Immunohistochemistry (IHC)
    5. Others
  9. Global Hemato Oncology Testing Market Analysis and Projection, By End User
    1. Segment Overview
    2. Hospitals
    3. Academic & Research Institutes
    4. Others
  10. Global Hemato Oncology Testing Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  11. Global Hemato Oncology Testing Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Hemato Oncology Testing Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  12. Company Profiles
    1. F. Hoffman-La Roche Ltd
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Abbott Laboratories 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  EntroGen, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   Qiagen N.V.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Cepheid
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Thermo Fisher Scientific, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Bio-Rad Laboratories, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Illumina, Inc.
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

List of Table

  1. Global Hemato Oncology Testing Market, By Product, 2022-203(USD Billion)
  2. Global Assay Kits & Reagents, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  3. Global Services, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  4. Global Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  5. Global Leukemia, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  6. Global Lymphoma, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  7. Global Multiple Myeloma, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  8. Global Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  9. Global Polymerase Chain Reaction (PCR), Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  10. Global Next-Generation Sequencing (NGS), Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  11. Global Immunohistochemistry (IHC), Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  12. Global Others, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  13. Global Hemato Oncology Testing Market, By End User, 2022-2032(USD Billion)
  14. Global Hospitals, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  15. Global Academic & Research Institutes, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  16. Global Others, Hemato Oncology Testing Market, By Region, 2022-2032(USD Billion)
  17. North America Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  18. North America Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  19. North America Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  20. U.S.  Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  21. U.S.  Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  22. U.S.  Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  23. Canada Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  24. Canada Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  25. Canada Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  26. Mexico Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  27. Mexico Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  28. Mexico Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  29. Europe Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  30. Europe Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  31. Europe Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  32. Germany Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  33. Germany Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  34. Germany Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  35. France Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  36. France Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  37. France Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  38. U.K.  Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  39. U.K.  Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  40. U.K.  Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  41. Italy Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  42. Italy Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  43. Italy Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  44. Spain Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  45. Spain Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  46. Spain Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  47. Asia Pacific Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  48. Asia Pacific Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  49. Asia Pacific Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  50. Japan Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  51. Japan Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  52. Japan Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  53. China Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  54. China Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  55. China Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  56. India Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  57. India Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  58. India Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  59. South America Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  60. South America Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  61. South America Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  62. Brazil Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  63. Brazil Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  64. Brazil Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  65. The Middle East and Africa Hemato Oncology Testing Market, By Product, 2022-2032(USD   Billion)
  66. The Middle East and Africa Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD   Billion)
  67. The Middle East and Africa Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)
  68. UAE Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  69. UAE Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  70. UAE Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion) 
  71. South Africa Hemato Oncology Testing Market, By Product, 2022-2032(USD Billion)
  72. South Africa Hemato Oncology Testing Market, By Cancer Type, 2022-2032(USD Billion)
  73. South Africa Hemato Oncology Testing Market, By Technology, 2022-2032(USD Billion)

List of Figures 

  1. Global Hemato Oncology Testing Market Segmentation
  2. Hemato Oncology Testing Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Hemato Oncology Testing Market
  9. Top Winning Strategies, 2022-2032
  10. Top Winning Strategies, By Development, 2022-2032(%)
  11. Top Winning Strategies, By Company, 2022-2032
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2022
  18. Market Share Analysis, 2022
  19. Restraint and Drivers:  Hemato Oncology Testing Market
  20. Hemato Oncology Testing Market Segmentation, By Product
  21. Hemato Oncology Testing Market For Assay Kits & Reagents, By Region, 2022-2032 ($ Billion)
  22.  Hemato Oncology Testing Market For Services, By Region, 2022-2032 ($ Billion)
  23.  Hemato Oncology Testing Market Segmentation, By Cancer Type
  24.  Hemato Oncology Testing Market For Leukemia, By Region, 2022-2032 ($ Billion)
  25.  Hemato Oncology Testing Market For Lymphoma, By Region, 2022-2032 ($ Billion)
  26. Hemato Oncology Testing Market For Multiple Myeloma, By Region, 2022-2032 ($ Billion)
  27. Hemato Oncology Testing Market Segmentation, By Technology
  28. Hemato Oncology Testing Market For Polymerase Chain Reaction (PCR), By Region, 2022-2032 ($ Billion)
  29. Hemato Oncology Testing Market For Next-Generation Sequencing (NGS), By Region, 2022-2032 ($ Billion)
  30. Hemato Oncology Testing Market For Immunohistochemistry (IHC), By Region, 2022-2032 ($ Billion)
  31. Hemato Oncology Testing Market For Others, By Region, 2022-2032 ($ Billion)
  32. Hemato Oncology Testing Market Segmentation, By End User
  33. Hemato Oncology Testing Market For Hospitals, By Region, 2022-2032 ($ Billion)
  34. Hemato Oncology Testing Market For Academic & Research Institutes, By Region, 2022-2032 ($ Billion)
  35. Hemato Oncology Testing Market For Others, By Region, 2022-2032 ($ Billion)
  36. F. Hoffman-La Roche Ltd: Net Sales, 2022-2032 ($ Billion)
  37. F. Hoffman-La Roche Ltd: Revenue Share, By Segment, 2022 (%)
  38. F. Hoffman-La Roche Ltd: Revenue Share, By Region, 2022 (%)
  39. Abbott Laboratories: Net Sales, 2022-2032 ($ Billion)
  40. Abbott Laboratories: Revenue Share, By Segment, 2022 (%)
  41. Abbott Laboratories: Revenue Share, By Region, 2022 (%)
  42. EntroGen, Inc.: Net Sales, 2022-2032 ($ Billion)
  43. EntroGen, Inc.: Revenue Share, By Segment, 2022 (%)
  44. EntroGen, Inc.: Revenue Share, By Region, 2022 (%)
  45. Qiagen N.V.: Net Sales, 2022-2032 ($ Billion)
  46. Qiagen N.V.: Revenue Share, By Segment, 2022 (%)
  47. Qiagen N.V.: Revenue Share, By Region, 2022 (%)
  48. Cepheid: Net Sales, 2022-2032 ($ Billion)
  49. Cepheid: Revenue Share, By Segment, 2022 (%)
  50. Cepheid: Revenue Share, By Region, 2022 (%)
  51. Thermo Fisher Scientific, Inc.: Net Sales, 2022-2032 ($ Billion)
  52. Thermo Fisher Scientific, Inc.: Revenue Share, By Segment, 2022 (%)
  53. Thermo Fisher Scientific, Inc.: Revenue Share, By Region, 2022 (%)
  54. Bio-Rad Laboratories, Inc.: Net Sales, 2022-2032 ($ Billion)
  55. Bio-Rad Laboratories, Inc.: Revenue Share, By Segment, 2022 (%)
  56. Bio-Rad Laboratories, Inc.: Revenue Share, By Region, 2022 (%)
  57. Illumina, Inc.: Net Sales, 2022-2032 ($ Billion)
  58. Illumina, Inc.: Revenue Share, By Segment, 2022 (%)
  59. Illumina, Inc.: Revenue Share, By Region, 2022 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2022
Tables & Figures:120
Pages:249
Countries covered:17
Companies covered::20
Forecast CAGR:8.13%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies